Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.71 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.71 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.71 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.71 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.71 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.71 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.71 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7940044 | 1.00 | CYP2D6 (0.71) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| SCHEMBL6811671 | 1.00 | CYP2D6 (0.71) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL6702711 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL6800343 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL8337144 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL5517640 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL4248 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| Traxoprodil SCHEMBL5888841 | 0.83 | GRIN2B (1.00) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| SCHEMBL7077436 | 0.83 | KCNH2 (0.50) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B | |
| SCHEMBL7948894 | 0.83 | KCNH2 (0.50) | CYP2D6GRIN2BKCNH2GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0828513-B1 | COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS | PFIZER (US) | 2004-01-21 | — | — | EP | disclosed |
| EP-0777652-B1 | NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES | PFIZER (US) | 2003-06-25 | — | — | EP | disclosed |
| US-6258827-B1 | HYDROXYAROMATIC HETEROCYCLIC ALKANOLS AND LEVODOPA | PFIZER INC. | 2001-07-10 | — | — | US | disclosed |
| EP-0828513-A2 | COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS | PFIZER INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0777652-A1 | NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES | PFIZER INC. (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996037226-A2 | COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS | PFIZER INC. (US) | 1996-11-28 | — | — | WO | disclosed |
| WO-1996006081-A1 | NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES | PFIZER INC. (US) | 1996-02-29 | — | — | WO | disclosed |